Boston Scientific Stresses Cardiology R&D, Makes Over Business Units

Boston Scientific's planned launches of IVUS systems, cutting balloons and embolic protection devices will allow the firm to buttress its drug-eluting stent offering with core cardiovascular growth

More from Archive

More from Medtech Insight